Australia Markets closed

Allogene Therapeutics Inc (ALLO) Q3 2021 Earnings Call Transcript

·41-min read
Allogene Therapeutics Inc (ALLO) Q3 2021 Earnings Call Transcript
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • ALLO

Hello, thank you for standing by, and welcome to Allogene Therapeutics Third Quarter 2021 Conference Call. After the market closed today, Allogene issued a press release that provides a corporate update and financial results for Q3 2021. Joining me on the call today are Dr. David Chang, President and Chief Executive Officer; Dr. Rafael Amado, Executive Vice President of Research and Development and Chief Medical Officer; and Dr. Eric Schmidt, Chief Financial Officer.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting